AXIN2 and non-small cell lung carcinoma: Thus, our demonstration that simultaneous suppression of these genes is biologically and clinically attributable to miR-582-3p upregulation reveals a new regulatory mechanism that contributes to the concomitant inactivation of AXIN2, DKK3 and SFRP1 in NSCLC.